non injectable glp-1 glp 1 injection The Rise of the GLP-1s: Beyond Diabetes and Obesity Comparing Ozempic, Wegovy and Other
Description
Currently, there are no FDA-approved treatments for NASH
As a result, lawsuits claim the manufacturer failed to warn that the continuous use of Ozempic and Wegovy can cause some individuals to experience prolonged and chronic delays in stomach emptying
Ozempic prescribing information and Instructions for Use, revised November 2024
Gastrointestinal changes are common
If the therapy has been interrupted for a long time, the body is no longer adapted to the physiological changes caused by the medication
